777 results found
The Australian Government commissioned a review of the clinical effectiveness of 16 natural therapies excluded from private health insurance rebates in April 2019. The Department of Health and Aged Care engaged National Health and Medical Research Council (NHMRC) to assist in its review by commissioning evidence evaluations that assessed published scientific research on the excluded therapies. NHMRC completed its role in the Natural Therapies Review 2024 with submission of all finalised evidence evaluations to the Department of Health and Aged Care in January 2025.
The purpose of this report is to provide a summary of feedback received as part of the national consultation to review NHMRC’s Indigenous Research Excellence Criteria (IREC).
NHMRC provides advice about the care of people in post-coma unresponsiveness (vegetative state) or a minimally responsive state.
The purpose of the Australian code for the care and use of animals for scientific purposes (the Code) is to promote the ethical, humane and responsible care and use of animals used for scientific purposes. It provides guidance for investigators, institutions, animals ethics committees, animal carers and all those involved in the care and use of animals for scientific purposes.The Code is adopted into legislation in all Australian states and territories. It is endorsed by the National Health and Medical Research Council (NHMRC), Australian Research Council, Commonwealth Scientific and Industrial Research Organisation and Universities Australia. Compliance with the Code is a prerequisite for receipt of NHMRC funding.A web version of the Code is provided below.A PDF version of the Code, and guidance documents about implementation of Section 7: Cosmetic testing, are available under 'Downloads'
NHMRC recognises excellence in the health and medical research sector through its annual Research Excellence Awards. Find our 2023 award winners listed below.
The guidelines are produced by the National Health and Medical Research Council (NHMRC) in collaboration with the Australian Commission on Safety and Quality in Healthcare, and are published on the MAGICapp platform.
It is currently estimated that 433,000 Australians are living with dementia, the second leading cause of death of all Australians.1 A long-term approach to the diagnosis and treatment of dementia is essential for Australia's social and economic wellbeing.
The Australian Government Department of Health and Aged Care (the department) and National Health and Medical Research Council (NHMRC) undertook consultation processes to provide an opportunity for members of the public, peak bodies, experts and other interested stakeholders to consider mitochondrial donation in the Australian context.
The National Health and Medical Research Council (NHMRC) remains committed to supporting dementia research in Australia following the end of the Australian Government's Boosting Dementia Research Initiative (BDRI).